Merck Wilmington Biotech's 470,000-square-foot facility, located at the Chestnut Run Innovation and Science Park, will include a research lab, manufacturing plant, and warehouse.

Merck broke ground on a $1 billion, 470,000-square-foot state-of-the-art biologics center of excellence in Wilmington, Del., the Rahway-based company announced April 29.

"The Merck Wilmington Biotech site represents our continued commitment to growing our investments in U.S. manufacturing and has the potential to create thousands of high-paying American jobs while ...

Merck has revealed that it is breaking ground on $1 billion plant in Wilmington, Delaware, which will produce the company's mega-blockbuster Keytruda.

Merck Wilmington Biotech will serve as a launch and commercial production facility and the future U.S. home for KEYTRUDA RAHWAY, N.J., April 29, 2025--(BUSINESS WIRE)--Merck (NYSE: MRK), known as ...

Merck to build new $1B biologics manufacturing facility in Wilmington, Delaware. Merck CEO Robert Davis joins 'Mornings with Maria' to discuss the new $1 billion biologics manufacturing facility ...

U.S. biopharmaceutical giant Merck announced the start of construction for a $1-billion, 470,000-sq-ft biologics center of excellence in Wilmington, Del. Officially called Merck Wilmington Biotech ...

Merck, known as MSD outside of the United States and Canada, announced the start of construction for a $1 billion, 470,000-square-foot state-of-the-art biologics center of excellence in Wilmington, ...

It will build a Wilmington, Delaware facility dedicated to making its cancer drug, Keytruda, for U.S. patients. Merck to invest $1 billion in U.S. drug manufacturing plant Skip to main content ...

Merck Wilmington Biotech will serve as a launch and commercial production facility and the future U.S. home for KEYTRUDA RAHWAY, N.J.--(BUSINESS WIRE)-- Merck, known as MSD outside of the United ...